Screener
Corvus Pharmaceuticals CRVS Price / book
Price / book at other companies
Other financials
Where this comes from
Calculated from Corvus Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The source filing: Corvus Pharmaceuticals’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:05 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-057100
FAQ
- What is Corvus Pharmaceuticals's price / book?
- Corvus Pharmaceuticals (CRVS) reported price / book of 5.1× in Q1 2026.
- How has Corvus Pharmaceuticals's price / book changed year-over-year?
- Corvus Pharmaceuticals's price / book increased by 16.2% year-over-year, from 4.4× to 5.1×.
- What is the long-term trend for Corvus Pharmaceuticals's price / book?
- Over 5 years (2020 to 2025), Corvus Pharmaceuticals's price / book has grown at a 32.5% compound annual growth rate (CAGR), from 2.3× to 9.4×.
- What does price / book mean?
- Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.
Ask your AI about Corvus Pharmaceuticals's price / book.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude